{
    "2019-03-05": [
        [
            {
                "time": "",
                "original_text": "百济神州交出港股上市首份成绩单，抗癌药巨子离赚钱有多远？",
                "features": {
                    "keywords": [
                        "百济神州",
                        "港股",
                        "抗癌药",
                        "盈利"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "外资狂买到“红线”，大族激光：关门，只准出不准进",
                "features": {
                    "keywords": [
                        "外资",
                        "大族激光",
                        "买入限制"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "大涨是调仓换股转变思路的好机会",
                "features": {
                    "keywords": [
                        "调仓换股",
                        "投资策略",
                        "市场机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "4+7集采爆发洪荒之力，药价降速如“闪电”",
                "features": {
                    "keywords": [
                        "4+7集采",
                        "药价",
                        "降价"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：首部《罕见病诊疗指南》发布",
                "features": {
                    "keywords": [
                        "医药生物",
                        "罕见病",
                        "诊疗指南"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "政府工作报告：培育五大新兴产业集群，壮大数字经济",
                "features": {
                    "keywords": [
                        "政府工作报告",
                        "新兴产业",
                        "数字经济"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "数字经济"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "5大仿制药将发力止痛药领域",
                "features": {
                    "keywords": [
                        "仿制药",
                        "止痛药",
                        "医药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "科创板、A股其他板块与港股市场IPO制度及定价估值体系对比分析——会议纪要",
                "features": {
                    "keywords": [
                        "科创板",
                        "A股",
                        "港股",
                        "IPO",
                        "定价估值"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "百济神州亏损6.74亿美元：研发支出超过恒瑞，能否烧出未来？",
                "features": {
                    "keywords": [
                        "百济神州",
                        "亏损",
                        "研发支出",
                        "恒瑞"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "基石药业负重上市，研发费用高企亏损扩大，亏损",
                "features": {
                    "keywords": [
                        "基石药业",
                        "上市",
                        "研发费用",
                        "亏损"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "东北证券【产品】公募产品回顾",
                "features": {
                    "keywords": [
                        "东北证券",
                        "公募产品",
                        "回顾"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上市推荐指引受关注，生物医药企业或成科创板申报主力",
                "features": {
                    "keywords": [
                        "上市推荐",
                        "生物医药",
                        "科创板"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}